Novinky<\/h1><\/span><\/div><\/div><\/div>P\u0159ehled nejnov\u011bj\u0161\u00edch poznatk\u016f Quinta\u2011Analytica, firemn\u00edch aktualit a kl\u00ed\u010dov\u00fdch trend\u016f ve farmaceutick\u00e9m pr\u016fmyslu<\/p>\n<\/div><\/div><\/div><\/div><\/div>
- <\/span><\/a><\/span>
![](\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%272560%27%20height%3D%271340%27%20viewBox%3D%270%200%202560%201340%27%3E%3Crect%20width%3D%272560%27%20height%3D%271340%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\")
<\/div><\/div>15 \u010dervence 2026<\/p>\n<\/div>
Quinta-Analytica Awarded the EcoVadis Gold Medal<\/p>\n<\/div>
Quinta-Analytica has been awarded the EcoVadis Gold Medal after achieving an overall sustainability score of 84 out of 100. The result represents a substantial increase from 68 points in the previous assessment and places the company in the 97th percentile globally.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span><\/div><\/div>
16 dubna 2026<\/p>\n<\/div>
Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC<\/p>\n<\/div>
Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span><\/div><\/div>
25 b\u0159ezna 2026<\/p>\n<\/div>
ADC Webinar: DAR, Bioanalysis and Intact MS in Next-Generation ADC Development<\/p>\n<\/div>
On behalf of Conscio Group, registration is now open for our free expert-led webinar on DAR characterization, bioanalytical strategy and mass spectrometry insight in ADC development.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
![](\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%272560%27%20height%3D%271440%27%20viewBox%3D%270%200%202560%201440%27%3E%3Crect%20width%3D%272560%27%20height%3D%271440%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\")
<\/div><\/div>17 prosince 2025<\/p>\n<\/div>
PF 2026: Thank You from Quinta-Analytica<\/p>\n<\/div>
In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span><\/div><\/div>
15 prosince 2025<\/p>\n<\/div>
IVBE for locally acting drugs: insights from Conscio Science Day in Munich<\/p>\n<\/div>
Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial?\nYes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span><\/div><\/div>
20 listopadu 2025<\/p>\n<\/div>
Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus<\/p>\n<\/div>
On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span><\/div><\/div>
11 z\u00e1\u0159\u00ed 2025<\/p>\n<\/div>
Meet us at CPHI 2025<\/p>\n<\/div>
This October, the global pharmaceutical community will gather in Frankfurt for CPHI 2025. Quinta-Analytica as a member of Conscio Group will be there too \u2013 visit us in the Contract Manufacturing Hall 5.1, Stand F1.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span><\/div><\/div>
8 z\u00e1\u0159\u00ed 2025<\/p>\n<\/div>
Quinta-Analytica successfully passed two onsite FDA inspections<\/p>\n<\/div>
In the first half of 2025, Quinta-Analytica underwent two onsite inspections by the U.S. Food and Drug Administration (FDA). <\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span><\/div><\/div>
5 srpna 2025<\/p>\n<\/div>
Preclinical Bioanalysis That Accelerates Clinical Entry<\/p>\n<\/div>
How fit-for-purpose and GLP-compliant bioanalysis can streamline your path to IND and CTA approvals.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span><\/div><\/div>
21 \u010dervence 2025<\/p>\n<\/div>
Boosting Bioanalytical Power for our clients<\/p>\n<\/div>
New ICP-MS Expands Our Capabilities<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span><\/div><\/div>
9 \u010dervence 2025<\/p>\n<\/div>
HER-096: A possible breakthrough in Parkinson\u2019s disease treatment<\/p>\n<\/div>
This testimonial highlights our collaboration with Herantis Pharma on the analytical development and nonclinical support for HER-096, a promising candidate in the fight against Parkinson\u2019s disease.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span><\/div><\/div>
9 \u010dervna 2025<\/p>\n<\/div>
Ensuring Success in Buccal Film Development: The Midazolam Film Case Study<\/p>\n<\/div>
Fast, Simple, Effective: Unlocking the Potential of Midazolam Films<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span><\/div><\/div>
15 kv\u011btna 2025<\/p>\n<\/div>
From Analytical Similarity to Clinical Data: Tailoring Evidence for Biosimilar Approval<\/p>\n<\/div>
On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
![](\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%272667%27%20height%3D%271500%27%20viewBox%3D%270%200%202667%201500%27%3E%3Crect%20width%3D%272667%27%20height%3D%271500%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\")
<\/div><\/div>16 prosince 2024<\/p>\n<\/div>
Welcome, 2025!<\/p>\n<\/div>
Reflecting on 2024 with gratitude and looking ahead with optimism.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
![](\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%272858%27%20height%3D%271496%27%20viewBox%3D%270%200%202858%201496%27%3E%3Crect%20width%3D%272858%27%20height%3D%271496%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\")
<\/div><\/div>2 prosince 2024<\/p>\n<\/div>
A Decade of Partnership with Adamed Pharma<\/p>\n<\/div>
Adamed Pharma and Quinta-Analytica\u2019s 10 \u2013 Year Journey in Pharma Innovation<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span><\/div><\/div>
25 listopadu 2024<\/p>\n<\/div>
Expediting Biosimilar development: Streamlining the path from research to market<\/p>\n<\/div>
On behalf of the Conscio Group, we would like to invite you to a free webinar on the future of the biosimilar pathway to approval, which is now open for registration.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span><\/div><\/div>
18 z\u00e1\u0159\u00ed 2024<\/p>\n<\/div>
Determination of total bound iron in human blood serum samples<\/p>\n<\/div>
Ironing out the challenges: measuring total bound iron in blood serum in Ferric Carboxymaltose (FCM) Studies<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span><\/div><\/div>
4 z\u00e1\u0159\u00ed 2024<\/p>\n<\/div>
Meet us at the heart of Pharma at CPHI 2024<\/p>\n<\/div>
As a part of Conscio Group, we are attending CPHI 2024 in Milan, Italy.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
P\u0159ehled nejnov\u011bj\u0161\u00edch poznatk\u016f Quinta\u2011Analytica, firemn\u00edch aktualit a kl\u00ed\u010dov\u00fdch trend\u016f ve farmaceutick\u00e9m pr\u016fmyslu<\/p>\n<\/div><\/div><\/div><\/div><\/div>
- <\/span><\/a><\/span>
15 \u010dervence 2026<\/p>\n<\/div>
Quinta-Analytica Awarded the EcoVadis Gold Medal<\/p>\n<\/div>
Quinta-Analytica has been awarded the EcoVadis Gold Medal after achieving an overall sustainability score of 84 out of 100. The result represents a substantial increase from 68 points in the previous assessment and places the company in the 97th percentile globally.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
16 dubna 2026<\/p>\n<\/div>
Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC<\/p>\n<\/div>
Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
25 b\u0159ezna 2026<\/p>\n<\/div>
ADC Webinar: DAR, Bioanalysis and Intact MS in Next-Generation ADC Development<\/p>\n<\/div>
On behalf of Conscio Group, registration is now open for our free expert-led webinar on DAR characterization, bioanalytical strategy and mass spectrometry insight in ADC development.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
17 prosince 2025<\/p>\n<\/div>
PF 2026: Thank You from Quinta-Analytica<\/p>\n<\/div>
In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
15 prosince 2025<\/p>\n<\/div>
IVBE for locally acting drugs: insights from Conscio Science Day in Munich<\/p>\n<\/div>
Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial?\nYes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
20 listopadu 2025<\/p>\n<\/div>
Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus<\/p>\n<\/div>
On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
11 z\u00e1\u0159\u00ed 2025<\/p>\n<\/div>
Meet us at CPHI 2025<\/p>\n<\/div>
This October, the global pharmaceutical community will gather in Frankfurt for CPHI 2025. Quinta-Analytica as a member of Conscio Group will be there too \u2013 visit us in the Contract Manufacturing Hall 5.1, Stand F1.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
8 z\u00e1\u0159\u00ed 2025<\/p>\n<\/div>
Quinta-Analytica successfully passed two onsite FDA inspections<\/p>\n<\/div>
In the first half of 2025, Quinta-Analytica underwent two onsite inspections by the U.S. Food and Drug Administration (FDA). <\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
5 srpna 2025<\/p>\n<\/div>
Preclinical Bioanalysis That Accelerates Clinical Entry<\/p>\n<\/div>
How fit-for-purpose and GLP-compliant bioanalysis can streamline your path to IND and CTA approvals.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
21 \u010dervence 2025<\/p>\n<\/div>
Boosting Bioanalytical Power for our clients<\/p>\n<\/div>
New ICP-MS Expands Our Capabilities<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
9 \u010dervence 2025<\/p>\n<\/div>
HER-096: A possible breakthrough in Parkinson\u2019s disease treatment<\/p>\n<\/div>
This testimonial highlights our collaboration with Herantis Pharma on the analytical development and nonclinical support for HER-096, a promising candidate in the fight against Parkinson\u2019s disease.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
9 \u010dervna 2025<\/p>\n<\/div>
Ensuring Success in Buccal Film Development: The Midazolam Film Case Study<\/p>\n<\/div>
Fast, Simple, Effective: Unlocking the Potential of Midazolam Films<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
15 kv\u011btna 2025<\/p>\n<\/div>
From Analytical Similarity to Clinical Data: Tailoring Evidence for Biosimilar Approval<\/p>\n<\/div>
On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
16 prosince 2024<\/p>\n<\/div>
Welcome, 2025!<\/p>\n<\/div>
Reflecting on 2024 with gratitude and looking ahead with optimism.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
2 prosince 2024<\/p>\n<\/div>
A Decade of Partnership with Adamed Pharma<\/p>\n<\/div>
Adamed Pharma and Quinta-Analytica\u2019s 10 \u2013 Year Journey in Pharma Innovation<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
25 listopadu 2024<\/p>\n<\/div>
Expediting Biosimilar development: Streamlining the path from research to market<\/p>\n<\/div>
On behalf of the Conscio Group, we would like to invite you to a free webinar on the future of the biosimilar pathway to approval, which is now open for registration.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
18 z\u00e1\u0159\u00ed 2024<\/p>\n<\/div>
Determination of total bound iron in human blood serum samples<\/p>\n<\/div>
Ironing out the challenges: measuring total bound iron in blood serum in Ferric Carboxymaltose (FCM) Studies<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>
4 z\u00e1\u0159\u00ed 2024<\/p>\n<\/div>
Meet us at the heart of Pharma at CPHI 2024<\/p>\n<\/div>
As a part of Conscio Group, we are attending CPHI 2024 in Milan, Italy.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/li>\n
- <\/span><\/a><\/span>